Hasbiotech
Company

date founded

Financing round

General

About Company
Hasbiotech is a Turkish company that develops new treatments for various diseases.

Industry

Sector :

Subsector :

Keywords :

founded date

01.01.2009

IPO status

Private

Description

The company focuses on researching drugs for hematologic, metabolic, chronic, oncological, and wound diseases. In addition to developing new treatments, Hasbiotech imports products from Cuba, such as a product that prevents amputation in diabetic foot ulcers. The company invests in drugs that provide innovative solutions to diseases like heart attack and Alzheimer's. Hasbiotech also plans to manufacture an original Turkish medicine from scratch, including raw materials.
Contacts
Similar Companies
999
Mabion S.A.

Mabion S.A.

The company is called Mabion S.A.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

Konstantynów Łódzki, Poland
Cocoon Biotech

Cocoon Biotech

Cocoon Biotech uses silk protein to develop innovative products for the treatment of osteoarthritis and other degenerative joint disorders.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care

Location

Cambridge, MA, USA

total rounds

4

total raised

$5.75M
Hemispherian

Hemispherian

Hemispherian is a biotechnology firm that develops new cancer treatments.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Software, Information Technology

Location

Oslo, Norway

total rounds

9

total raised

$17.78M
Protein Alternatives

Protein Alternatives

ProAlt is a biotech company developing innovative products for the detection and treatment of cancers.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Medical

Location

Madrid, Spain

total rounds

1

total raised

$2.58M
M&A Details
1

Acquired by

BUBA (BUMED Business Angels)

announced date

10.07.2020

price

$2M

Financials

Co-Investors

Activity

Recent News
0